SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-019208
Filing Date
2020-04-28
Accepted
2020-04-28 16:09:34
Documents
5
Period of Report
2020-06-16
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2020 snss-def14a_20200616.htm DEF 14A 1136405
2 GRAPHIC gjg5kcofem0u000001.jpg GRAPHIC 2227
3 GRAPHIC gjg5kcofem0u000002.jpg GRAPHIC 1504
4 GRAPHIC gjg5kcofem0u000004.jpg GRAPHIC 1547
5 GRAPHIC gjg5kcofem0u000003.jpg GRAPHIC 2227
  Complete submission text file 0001564590-20-019208.txt   1148573
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-51531 | Film No.: 20825072
SIC: 2834 Pharmaceutical Preparations